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The type I intermediate filament protein keratin 17 (K17) is normally absent in the 
interfollicular epidermis but is robustly induced in the setting of inflammatory skin disorders 
such as psoriasis and cancer. Our recent research indicated that genetic loss of Krt17 results in 
a delayed onset of tumor development correlating with reduced expression of pro-
inflammatory genes and attenuated inflammation in mouse models for basal cell carcinoma 
(Gli2-transgenic) and squamous cell carcinoma (HPV16-transgenic). However, no effort has 
yet been made to define the role of keratins in the specific stages of carcinogenesis, in particular 
in the initial oncogenic stresses that lead to subsequent tumor development. Herein, we sought 
to elucidate whether K17 expression is responsive to DNA damage, and if the presence or 
absence of K17 would alter the DNA damage response. 
Using immunofluorescence microscopy, Western blotting and qRT-PCR, we assessed 
the DNA damage response in HPV16Tg/+ mice at postnatal day 50 (P50) in the presence or 
absence of a functional Krt17 gene, corresponding to a chronic model for tumor initiation 
(n=3 biological replicates). For all mice, we acquired tissue sections, RNA, and protein extracts 
from ear, back, tail, and liver tissues. 
Preliminary findings indicate that DNA damage occurs in the HPV16-transgenic 
model, independent of K17 status. Additionally, this body of work sheds new light on the 
extent of DNA damage in different epidermal tissue sites in the HPV16-transgenic model. 
Intriguingly, a pilot study of DMBA-initiated DNA damage reveals a potential induction of 
K17, a finding that would be congruous with the established inducible nature of K17. 
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I N T R O D U C T I O N  
 
Types of intermediate filaments 
The very basis of cellular architecture, and more specifically the unique structure that 
various cells retain, is derived from a complex network of fibrous proteins that provide 
mechanical and structural support, among other roles. These functions are attributed to three 
kinds of filamentous cytoskeletal proteins, namely microfilaments (F-actin ~6 nm), 
microtubules (tubulin ~25 nm) and intermediate filaments (IF), defined by their intermediary 
diameter of ~10 nm (Fuchs and Weber, 1994; Wickstead and Gull, 2011). In part, biochemical 
analyses and immunofluorescence microscopy have revealed unique subsets of intermediate 
filaments that could be organized based upon the cell type and subcellular localization (Franke 
et al., 1978). This was somewhat surprising given the conserved tripartite structure and rod 
domain sequence largely similar among IF proteins. However, it was ascertained that the 
variability specific to the amino-terminal and carboxyl-terminal end domains gives rise to the 
functional diversity of intermediate filaments (Steinert and Roop, 1988). Now, it is understood 
that intermediate filaments fall into six primary categories with a diverse set of functions, 
including type V lamins, comprising nuclear lamina, and desmin, a type III IF that plays an 
integral role in the contractile constituents of myogenic cells (Figure 1; Chung et al., 2013; 
Paulin and Li, 2004). Due to our concentration on skin biology in the Coulombe laboratory, 
of particular interest to us are keratin (K) proteins, the type I and type II intermediate 
filaments, and consequently these IFs will be the focus of the remainder of this thesis. 
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Keratin family of proteins 
 Keratins are i) the largest family of intermediate filaments (with 54 genes in total), ii) 
characteristically epithelial in origin and iii) have molecular weights (MW) ranging from 40 to 
70 kDa (Schweizer et al., 2006; Sun et al., 1983). They are classified as type I or type II based 
on several molecular features, including gene substructure and sequence homology (Figure 
2A; Fuchs and Marchuk, 1983). In particular, type I keratins are acidic (pKa 4.5-5.5) whereas 
type II keratins are neutral or basic (pKa 6.5-8.5) (Fraser et al., 1972; Moll et al., 1982). 
Moreover, keratins have a number of key features including, but not limited to, the distinctive 
ability to self-assemble in vitro (Figure 2B) and to remain cytoplasmic under normal 
physiological conditions (Figure 2C) (Coulombe and Omary, 2002; Yamada et al., 2002). 
 As previously mentioned, keratins have a tripartite structure with a N-terminal head, 
central rod and C-terminal tail domains. Additionally, the central rod domain is comprised of 
α-helical subdomains of fixed length (1A, 1B, 2 A, 2B) separated by short linker regions (Figure 
2D; Bragulla and Homberger, 2009). The central rod domain of keratins features long-range 
Figure 1. Subtypes of intermediate filament proteins 
Intermediate filaments are predominantly organized into six different groups based on their tissue 
specificity and subcellular localization. Keratin proteins are found in the Type I and Type II groups. From 
Chung et al., 2013. 
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heptad repeat of hydrophobic/apolar amino acids that permit a unique coiled-coil interaction 
which preferentially forms between a type I and type II partner (Coulombe and Fuchs, 1990; 
Hatzfeld and Weber, 1990). Subsequent interactions between heterodimers lead to the 
formation of anti-parallel tetramers and ultimately to a ~10 nm wide keratin filament 
composed of lateral and longitudinal aggregations of these elongated tetrameric and octameric 
subunits (Aebi et al., 1983). 
 Reflecting in part a strict requirement for the heteromeric assembly of their protein 
products, type I and type II keratin genes are regulated in a pairwise, tissue- and differentiation-
specific fashion in epithelial cells. For example, the type II Krt5 and type I Krt14 genes are co-
expressed in the basal progenitor layer of epidermis and related complex epithelia, whereas the 
type II Krt8 and type I Krt18 genes are expressed in simple epithelia such as gut, liver, kidney 











Figure 2. Introduction to the organization and assembly of keratin proteins.  
(a) The 54 keratin proteins are organized into type I (“acidic”) and type II (“basic to neutral”) groupings 
that pair to form heteropolymeric filaments. (b) Electron microscopy image of IFs reconstituted in vitro 
from purified human K5 and K14 proteins. Scale bar, 100 μm. (c) Immunofluorescent staining of 
cytoplasmic localization of keratin filaments. Blue staining is DAPI. (d) Schematic demonstrating the 
assembly of keratin proteins into 10-12 nm filaments. The heterodimerization of type I and type II keratins 
occurs in a parallel and polar fashion. However, the formation of a tetramer proceeds in an apolar manner. 
Figure adapted from Coulombe et al., 2012.  
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Functional roles of keratins  
The notion that intermediate filaments, and keratins in particular, merely play 
structural roles has undergone a momentous paradigm shift. Although type I and II keratins 
are absolutely essential in maintaining cellular architecture, supporting the nucleus and 
providing mechanical resilience to a cell, a number of ancillary functions have been uncovered 
that underscore the pleiotropic nature of these proteins (Kim and Coulombe, 2007; Pallari and 
Eriksson, 2006; Toivola et al., 2010). In this section, both the mechanical and non-mechanical 
capacities of keratin proteins will be briefly discussed.  
A variety of external and internal stimuli can impose substantial stress upon cells, most 
notably in the skin. In response, eukaryotic epithelial cells have adapted means of withstanding 
the impact of mechanical forces through intricate networks of cytoplasmic keratin filaments. 
The micromechanical properties of keratins become most apparent in disease settings where 
mutations in keratin genes causes a variety of skin-related aberrations (Gu and Coulombe, 
2007). For example, two genetic diseases, epidermolysis bullosa simplex (EBS) and 
pachyonychia congenita (PC), are characterized by skin fragility and disrupted tissue 
architecture and homeostasis respectively, underscoring the structural role that keratins play 
(Coulombe and Fuchs, 1993; McLean et al., 1995).  
 Furthermore, keratins interact with organelles through a number of mechanisms. They 
have been implicated in having a functional relationship with mitochondria and in the cellular 
distribution of Golgi apparatus, evident in the dysregulation of Golgi reassembly in a cell line 
expressing a mutated K18 protein (Toivola et al., 2005). Keratins also have a capacity to target 
cellular proteins and are implicated in a variety of cellular signaling processes, readily apparent 
for the type I protein, keratin 17 (K17).  
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Physiological roles ascribed to K17 in normal skin epithelia 
 At baseline, K17 has a complex expression pattern. It is constitutively expressed in the 
hair follicle and other ectoderm-derived epithelial appendages (nail, glands, tooth, and thymus) 
and is displayed only in cells of certain types of complex epithelia (McGowan and Coulombe, 
1998; Panteleyev et al., 1997; Troyanovsky et al., 1989). Much of our knowledge about K17 in 
normal physiology has extended from initial observations in a K17 null mouse model 
(McGowan and Coulombe, 2002). As would be expected, K17, although absent from the 
interfollicular epidermis, plays a structural role in the postnatal hair follicle. This manifests 
itself in two primary functions: 1) providing mechanical strength and resistance to the hair 
shaft and 2) maintaining the viability of hair-producing epithelial cells in the outer root sheath 
and matrix (McGowan and Coulombe, 2002).  
 Consistent with the findings by Oshima (2002) that keratins influence apoptotic 
signaling, additional studies on K17 in the hair follicle have revealed a specific relationship 
between K17 and TNF-α in regulating normal hair follicle cycling (Tong and Coulombe, 2006). 
TNF-α is an endogenous pyrogen with a broad array of physiological responsibilities including 
inducing inflammation and apoptotic cell death. The molecular interaction between K17 and 
the TNF-α adaptor protein, TRADD, is required for the proper anagen-catagen transition 
(transition from the growth phase to the involution phase of the hair cycle), which would be 
otherwise disrupted by TNF-α (Commo and Bernard, 1997; Tong and Coulombe, 2006). This 
provides a concrete function for K17 in epithelial signaling pathways that extends beyond the 
established canonical roles for IFs.  
 A study by Kim et al. (2006) uncovered a newfound function of K17 in the Akt/mTOR 
signaling pathway and regulation of cell growth through the direct binding with the accessory 
protein 14-3-3σ. This is particularly notable in the context of tissue and wound repair. Using 
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cell mass and size as readouts, K17 knockout primary keratinocytes were significantly reduced 
in size as a result of attenuated de novo protein synthesis and, additionally, K17-/- embryos 
exhibited subsequent altered wound closure in vivo (Kim et al., 2006). This novel finding was 
striking and, as such, verification of this as a K17-specific role was necessary. Indeed, further 
biochemical analyses validated these findings and honed in on two particular amino acid 
residues in the amino-terminal head domain (Ser 9 and Ser 44) that are indispensable for these 
functions (Kim et al., 2006). Additionally, extensive studies on K17 in both disease settings 
and developmental processes of the skin have revealed its inducible nature (McGowan and 
Coulombe, 1998), hinting at potentially unrecognized contributions of K17. 
 
Keratin 17: A role in carcinogenesis 
 The body of evidence that Keratin 17, a 46 kDa type I keratin, plays a functional role 
in carcinogenesis has been mounting. Preliminary research on a ‘46,000 molecular weight 
(MW) cytokeratin’, now recognized as K17, corroborated its apparent absence from 
interfollicular epithelial tissue and uncovered its distinctive prominence in basal cell 
epithelioma (BCC) (Moll et al., 1982). Capitalizing on the generation of highly specific 
monoclonal antibodies for immunohistochemistry, Markey et al. (1992) confirmed in a study 
of 15 human patient samples the BCC-derived K17 expression in situ. Although these 
discoveries were momentous from a basic physiology standpoint, the true significance of K17 
in carcinogenesis was demonstrated through a comprehensive microarray of breast cancer 
tissue samples (van de Rijn et al., 2002). Herein, the authors analyzed over 600 paraffin-
embedded breast tumors and found a compelling association between the expression of K17 
in breast carcinoma cells and a poorer prognosis, as demonstrated by Kaplan-Meier survival 
analysis.  
 8 
Investigation of K17 in other pathologies has provided a more detailed insight into 
the molecular mechanisms by which K17 contributes to cancer. Early studies on psoriasis 
indicated that treatment with anti-psoriatic therapy dramatically reduced K17 expression in 
suprabasal keratinocytes (de Jong et al., 1991). This observation was striking as K17 had not 
been observed in healthy epidermal tissue but was upregulated in psoriatic conditions. In vitro 
studies in the human keratinocyte cell line, HaCaT, provided a mechanistic context in which 
K17 was involved in psoriatic lesions. In particular, IFN-γ, a central cytokine in the 
pathogenesis of psoriasis, was shown to transcriptionally activate K17 and the overexpression 
of IFN-γ led to hyperproliferation and dysregulated differentiation of keratinocytes 
(Bonnekoh et al., 1995; Vogel et al., 1995). These examples are not exhaustive since K17 
induction has been reported in a variety of other stress-related settings such as viral infection, 
acne and injury, to name a few (Hughes et al., 1996; Jin and Wang, 2013; Pan et al., 2011; Proby 
et al., 1993).  
 The common feature of many of these conditions is a robust inflammatory response, 
prompting the question whether K17 has a functional role in other settings with a similar 
context. As such, and building on the work conducted by van de Rijn et al. (2002) in breast 
cancer, K17 has now been identified as a prognostic marker and/or indicator of poorer clinical 
outcomes in a variety of epithelial-derived cancers including, cervical, ovarian, oral squamous 
cell carcinomas and gastric adenocarcinoma (Escobar-Hoyos et al., 2014; Ide et al., 2012; 
Kitamura et al., 2012; Wang et al., 2013). Unifying these two observations is the well-established 
connection between inflammation and cancer (Coussens and Werb, 2002; Lin and Karin, 
2007). Accordingly, significant efforts have been undertaken in the Coulombe laboratory to 
delineate the relationship between K17, inflammation and cancer in the skin. 
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 The advent of transgenic mouse models has opened up new avenues through which 
to enhance our understanding of cancer pathophysiology. A transgenic model for basal cell 
carcinoma (BCC) has been pivotal for developing a deeper understanding of how K17 is 
involved in carcinogenesis. The K5 promoter-driven overexpression of the transcription 
factor Gli2 results in the activation of the Sonic hedgehog (Shh) signaling pathway in an 
oncogenic manner. In turn, this leads to the development of multiple BCC lesions on ear, tail 
and trunk tissue (Grachtchouk et al., 2000). However, the genetic ablation of Krt17 in this 
setting impairs BCC lesion development and dramatically reduces the extent of epidermal 
hyperplasia (Figure 3A; DePianto et al., 2010). In both male and female mice, there is a 
significant delay in lesion onset as a result of K17 ablation (Figure 3B and 3C; DePianto et al., 
2010). Underpinning this is a reduction in inflammation and diminished level of cell 
proliferation that was seen in the Gli2tg; Krt17-/- mice, as revealed by a 3-fold reduction in 
mitotically active cells (DePianto et al., 2010). qRT-PCR analyses have also exhibited a global 
shift in cytokine expression, from Th1/Th17 (‘pro-inflammatory’) to Th2 (‘anti-












Figure 3. Genetic ablation of K17 delays tumor onset in a model of basal cell carcinoma. 
(a) Left panel indicates that P80 Gli2Tg mice spontaneously develop ear lesions however in K17 null mice 
the onset of these BCC-like lesions is delayed. Right panel, hematoxylin-eosin stained ear tissue 
demonstrating a dramatic reduction in the thickness of the ear epithelium upon genetic ablation of K17. (b) 
Cumulative percentage of mice with ear lesions stratified by sex and genotype during P40-P120 time frame. 
Both males and females exhibit delayed tumor onset and no significant difference in the length of the delay 
is evident between sexes. (c) Quantification of delay in K17 mice at P80 and representative of this as a K17- 




Building upon this work, a separate transgenic mouse model for squamous cell 
carcinoma (SCC) developed by Arbeit et al. (1994) was utilized to substantiate the impact of 
K17 on tumorigenesis. The human papillomavirus (HPV) is widely associated with a plethora 
of cancers and the targeted expression of HPV type 16 (HPV16) early genes in basal 
keratinocytes leads to SCC-like lesion formation in the skin, discussed in detail in the next 
section (Arbeit et al., 1994; Munoz et al., 2006). Correspondingly, genetic ablation of K17 in 
the HPV16Tg/+ setting (HPV16Tg/+; Krt17-/-) markedly reduces epidermal thickness in ear tissue, 
concomitant with alterations in determinants of tumor growth: angiogenesis, inflammation 
and mitotic activity (Figure 2A; Hobbs et al., 2015). To dissect the mechanism by which K17 
regulates pro-inflammatory gene signatures, a number of in vitro assays pointed to an 
interaction between K17, autoimmune regulator (Aire) and the ribonucleoprotein, hnRNP K, 
in impacting cytokine production (Figure 2B; Chung et al., 2015; Hobbs et al., 2015).  
 Epidermal malignancies are not the only setting in which K17 has a culpable role in 
carcinogenesis. Using the same HPV16Tg/+ model, Hobbs et al. (2015) showed that loss of K17 
attenuates disease progression in cervical cancer and has a more complex function than initially 
postulated, as the effects of K17 loss on immune response and inflammatory gene expression 
were distinct in this setting. This is further coupled with the findings that K17 influences cell 
adhesion and oncogenic transformation in the relatively uncommon bone cancer, Ewing 
sarcoma (Sankar et al., 2013). Although K17 plays an intricate part in inflammatory processes 
that directly influence tumor development, it is evident that these tissue-specific nuances 
encourage further investigation of a potentially more expansive role for K17 in cancer (Hobbs. 




Mouse skin carcinogenesis is a multistage process 
 Mouse skin provides a favorable stage for a more detailed investigation of the 
mechanisms that drive tumorigenesis for a number of reasons. Firstly, murine skin is readily 
accessible for tissue and sample procurement, macroscopic evaluation of lesions as they 
progressively develop, and treatment interventions. Secondly, the architecture of stratified 
squamous epithelium is well understood and a number of transgenic mouse models for skin 
cancer have been established (i.e. Gli2tg and HPV16Tg/+), enabling efficient genetic 
manipulation of the molecular target of interest. Lastly, mouse skin tumor development is 
Figure 4. Loss of K17 attenuates squamous cell carcinoma-like growth. 
(a) Hematoxylin-eosin stain of HPV16Tg/+ and HPV16Tg/+; Krt17-/- mouse ear sections at P70 
demonstrating a substantial increase in epidermal thickness. Quantification of epidermal thickness at both 
pre-lesional and lesional time points across wild-type, HPV16Tg/+ and HPV16Tg/+; Krt17-/- genotypes. Scale 
bars, 20 μm. Error bars, s.e.m. (b) In vitro analyses indicate that K17 induces a pro-inflammatory response 
based on the normalized expression levels of the 19 genes represented above. Figure adapted from Hobbs 






step-wise and ordered into discrete initiation, promotion and progression stages (Figure 5; 
Slaga et al., 1996). Broadly speaking, inflammation is a characteristic of each of these stages 
and, to date, the role of K17 in explicit stages of tumorigenesis has yet to be established. The 
models described, herein, will enable the identification of the stage(s) at which K17 may be 




In short, the initiation stage of carcinogenesis is characterized by an irreversible 
oncogenic event leading to DNA damage that occurs in a small number of susceptible skin 
epithelial cells. The effectors of this damage vary, including UV exposure and chemical 
carcinogens. However, in similar fashion, they all cause genetic alterations in either tumor 
suppressor (e.g. TP53/Trp53) or proto-oncogenes (e.g. H-Ras) that ‘initiate’ the process of 
Figure 5. Multistage model of mouse skin carcinogenesis. 
An oncogenic event, either chemical or genetic, is the major characteristic of the initiation stage of 
carcinogenesis. This insult can either be an activating mutation in a proto-oncogene or an inactivating 
mutation in a tumor suppressor gene. The promotion phase is characterized by a stark increase in pro-
inflammatory elements leading to epidermal hyperplasia. Additionally, these oncogenic insults lead to clonal 
expansion of the mutated cells. Progression results in the conversion of benign papillomas to invasive and 
malignant carcinomas resulting in widespread outgrowth of cancer cells and subsequent metastasis. 
Previous studies have demonstrated the involvement of Keratin 17 in the pro-inflammatory response, 
however no such work has been conducted on the association between K17 and the specific stages of 





tumor formation (Hennings et al., 1993; Quintanilla et al., 1986). These few transformed cells 
then undergo clonal expansion, aided by inflammatory processes, and often distinguished by 
a selective growth advantage over normal cells (Yuspa et al., 1982). Finally, the progression 
stage is typified by malignant transformation of cancer cells, as identified by increased genomic 
instability and telomerase activity, disrupted ECM interactions and metastasis (Bednarek et al., 
1995; Tennenbaum et al., 1992). 
 
HPV16Tg/+ model 
 The HPV16Tg/+ transgenic mouse is an elegant model for studying the development 
of HPV-induced SCC. Variability exists in the extent of neoplastic progression according to 
the specific virus type. Consequently, HPV type 16 was selected on the basis of its ability to 
cause high-grade lesions (Arbeit et al., 1994). This capacity largely arises from two specific 
‘early’ genes in the HPV genome: E6, which explicitly targets and degrades P53 and E7, which 
ultimately permits the release of the transcription factor, E2F, leading to increased and 
improperly regulated cellular proliferation (Figure 6A; Chellappan et al., 1992; Scheffner et al., 
1990). By using a K14 promoter to preferentially drive HPV16 transgene expression in basal 
keratinocytes (which express the K5 and K14 filaments), this model successfully targets the 
most proliferative cells in the epidermis, as well as the cells that are most affected by SCC 
lesions. Moreover, the invasive nature of the HPV16 virus results in full insertion into the host 
genome suggesting that DNA double strand breaks are a particularly common type of DNA 
damage in this setting (Gillespie et al., 2012; Williams et al., 2014). In this model, lesion onset 
tends to occur at postnatal day 60 (P60). Thus, the ‘prelesional’ time point at P50 is most 
similar to what would be considered the initiation stage (Figure 6C; Hobbs et al., 2015). By 
P120 there is complete penetrance of macroscopic lesion formation in ear tissue with 
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hyperkeratosis (Figure 6D). Notably, there is a robust upregulation of K17 between P20 and 
P40 in the interfollicular epidermis of the HPV16Tg/+ model that precedes the time point 




Two-step chemical carcinogenesis model 
 Pharmacological induction of carcinogenesis in mouse skin provides an additional 
route to evaluate the various contributions of molecular entities to tumor development. 
Traditionally, in the two-step chemical carcinogenesis model, two separate agents are used to 
Figure 6. HPV16Tg/+ model for squamous cell carcinoma. 
(a) Schematic depicting the K14 promoter, a keratin constitutively expressed in basal cells of the epithelium, 
driving the early genes of the human papillomavirus type 16 (HPV16), in particular E6 and E7, that gives 
rise to squamous cell carcinoma (SCC). (b) Representative image of a normal, wild-type ear. (c) and (d) 
depict ears of the HPV16 transgenic mouse model. (c) Image of a pre-lesional HPV16Tg/+ female ear at P45 
with increased vasculature. (d) Image of HPV16Tg/+ ear at P120 with significant squamous cell carcinoma 




chemically elicit the stages of initiation and promotion. 7,12-dimethylbenz[a]anthracene 
(DMBA) is a polycyclic aromatic hydrocarbon frequently used for its ability to cause 
widespread DNA damage. Specifically, DMBA administration causes an A to T transversion 
in the H-Ras gene with relatively high frequency, including in keratinocyte stem cells, which 
are thought to be the primary cellular target during initiation (Brown et al., 1990; Morris, 2004). 
Other mutagens can also be used to initiate cells in the two-step chemical carcinogenesis model 
reviewed by Abel et al. (2009).  
 Once initiated with a mutagen such as DMBA, a second exposure is used to enact the 
promotion stage of carcinogenesis. Again, a variety of agents can induce this phase. However, 
the most common one is the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) 
(Abel et al., 2004). Upon treatment with TPA, there is a robust and enhanced inflammatory 
response in the skin that spurs the formation of papillomas and subsequent invasive 
carcinomas (Mueller, 2006). Interestingly, using the A431 epidermoid carcinoma cell line, 
Hobbs et al. (2015) demonstrated that inflammatory cytokine induction by TPA treatment was 
K17-dependent and that shRNA knockdown or CRISPR/Cas9-mediated knockout of K17 
dramatically attenuated this TPA induction of cytokine expression. Of significant value to 
biological researchers is the fact that the stages of carcinogenesis and chemical administrations 
in this acute model can be separated both operationally and mechanistically (Abel et al., 2004).  
 
DNA damage as an indicator of initiation 
To properly ascertain the involvement of certain proteins (i.e. K17) in the initiation 
stage of carcinogenesis, a suitable transgenic mouse model or acute two-step treatment 
paradigm must be combined with an appropriate experimental readout. DNA damage is a 
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hallmark of initiation, since mutagenic events give rise to the ‘initiated’ cells primed for clonal 
expansion, and thus serves these purposes best. 
 In reaction to this insult, a number of DNA damage response (DDR) pathways are 
activated and, depending on the type of insult, certain pathways take charge to repair the 
damaged DNA. Collectively, this network functions through signal transduction cascades to 
prompt damage sensors, arrest cell cycle progression and recruit repair machinery to ultimately 
determine the fate of the cell at hand (Zhou and Elledge, 2000). Two central transducers of 
the DNA damage response are the phospho-inositide kinase (PIK)-related proteins, ATR and 
ATM (Zhou and Elledge, 2000). In turn, these proteins target the checkpoint kinases, CHK1 
and CHK2, respectively (Figure 7). Other noteworthy effectors are P53, colloquially known 
as ‘the guardian of the genome’, and BRCA1 (Lane, 1992). Yet, the network of DDR signaling 
is rather complex and a reliable proxy that broadly signifies the occurrence of DNA damage 
is necessary.  
Figure 7. γH2AX is a reliable marker of DNA damage 
The DNA damage response (DDR) pathways are a complex network that collectively integrate and respond 
to a variety of mutagenic insults. The phosphorylation of the histone variant H2AX (to γH2AX) occurs 
rapidly through ATM-mediated signaling and is an easily detectable and reliable readout for the occurrence 





Phosphorylation of the histone variant H2AX on serine-139 (thereafter referred to as 
γH2AX) rapidly occurs upon DNA damage, in particular upon double-strand breaks (DSBs) 
(Figure 7). In fact, the formation of γH2AX foci occurs within seconds of DNA damage, 
however it is more reliably detected 15-30 minutes after the insult (Sharma et al., 2012). 
Moreover, the number of foci is directly indicative of the extent of DNA damage as each foci 
represents a single DSB (Löbrich et al., 2010). This phosphorylation event not only modifies 
chromatin structure thus enabling repair machinery to more readily access affected DNA, but 
also acts to recruit DDR-associated proteins.  
The reliability of this marker has been widely documented due to its distinct 
advantages over comparable DDR proteins (BRCA1, 53BP1 etc.), including the fact that it is 
detectable in all cell cycle phases, as opposed to the more restricted expression of others (Polo 
and Jackson, 2011). Practically, it has been used in a number of different experimental assays: 
immunoblotting, immunostaining of tissue sections and flow cytometry, all of which enable 
the application of efficient quantification methods (Mah et al., 2010; Sharma et al., 2012). 
Suitably, a number of the experimental assays described in this thesis exploit the reliability and 
efficiency of this DNA damage marker.  
As an additional means of pinpointing the relationship between K17 and DNA 
damage, qRT-PCR analyses for prominent DDR genes was conducted, including those 
encoding for the major effectors of these signaling pathways. A detailed description of each 









Elevated DNA damage in the HPV16Tg/+ model compared to wild-type does not 
appear to be K17 dependent 
The HPV16Tg/+ model is a well-defined and previously reported paradigm for the 
development of intraepithelial lesions and subsequent squamous cell carcinomas that parallel 
those seen in human skin (SCC) (Arbeit et al., 1994; Hobbs et al., 2015). Prior documented 
research indicated that lesion development occurs between P60 and P120 in HPV16Tg/+ ear 
skin, with complete penetrance by P120 (Hobbs et al., 2015). As such, the pre-lesional time 
point defined for these studies reported here was determined to be P50. This time point 
coincides with characteristics that are shared by the initiation phase of carcinogenesis, 
including increased vascularization (“angiogenic switch”), heightened inflammation and 
cellular proliferation and suppression of apoptotic signaling (Coussens and Werb, 2002; Evan 
and Vousden, 2001; Hanahan and Folkman, 1996). More significantly, the P50 time point 
follows the upregulation of K17 in the interfollicular epidermis of HPV16Tg/+ mice between 
P20 and P40 (Hobbs et al., 2015). Further, the analyses reported below were conducted for 
both male and female mice, based on our previous findings of a sex bias in Gli2-induced 
tumorigenesis in mouse skin as well as in the hypertrophic and inflamed palmoplantar 
keratoderma lesions that spontaneously arise in K16 null mice (DePianto et al., 2010; Kerns et 
al., 2016; unpublished data from the Coulombe laboratory).  
To answer the question whether K17 plays a role in DNA damage processes prior to 
lesion onset in the HPV16Tg/+ model, tissue sections from pre-lesional male and female mice 
were obtained for the WT; Krt17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- genotypes 
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and analyzed for DNA damage markers. At the protein level, elevated DNA damage, 
demonstrated by immunoblotting for the histone variant γH2AX, is evident at the P50 time 
point in the HPV16Tg/+ female mice with or without a functional K17 gene (Figure 8). Indeed, 
there is a statistically significant increase in γH2AX in HPV16Tg/+; Krt17+/- and HPV16Tg/+; 
Krt17-/- back tissue compared to wild-type (p=0.01 and p=0.0001 respectively). The presence 
of K17 does not appear to significantly affect the amount of DNA damage present at that 
time point, in this model (p=0.78). A similar trend was apparent in the ear samples of both 
transgenic mouse cohorts compared to their wild-type counterparts (HPV16Tg/+; Krt17+/- vs 
WT, p=0.01; HPV16Tg/+; Krt17-/- vs WT, p=0.047, HPV16Tg/+; Krt17+/- vs HPV16Tg/+; Krt17-/-
, p=0.06). By contrast, tail tissue of all mice analyzed in this study did not exhibit pronounced 
levels of γH2AX, regardless of the genotype (Figure 8, 9).  
Correspondingly, male mice examined across all tissue sites and genotypes, exhibited 
an analogous phenomenon. Back tissue harvested from transgenic mice had elevated γH2AX 
protein levels compared to wild-type (HPV16Tg/+; Krt17+/- vs WT, p=0.028; HPV16Tg/+; Krt17-
/- vs WT, p=0.041), despite the lack of a significant difference between HPV16Tg/+; Krt17-/- 
and HPV16Tg/+; Krt17+/- mice (p=0.84). Ear tissue isolates in the male HPV16Tg/+ setting 
displayed increased γH2AX compared to wild-type (HPV16Tg/+; Krt17+/- vs WT, p=0.045; 
HPV16Tg/+; Krt17-/- vs WT, p=0.05) and no disparity arose between K17 heterozygous and 
null mice in the HPV16Tg/+ setting (p=0.70). The tail tissue lacked a noticeable amount of 
γH2AX. Consistent with previously published research by Hobbs et al. (2015), Keratin 17 
protein levels displayed a greater than 2-fold increase in the HPV16Tg/+ setting compared to 
wild-type at P50 (note that the substantive K17 levels detected in normal skin tissue at baseline 









Figure 8. Elevated DNA damage is exhibited in the HPV16Tg/+ setting compared to wild-type 
in female mice. 
Ear, back and tail tissue was harvested from female WT K17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+;  
Krt17-/- mice at age P50. Protein was isolated from each sample and anti-K17, anti-γH2AX and anti-











Figure 9. Elevated DNA damage is exhibited in the HPV16Tg/+ setting compared to wild-type 
in male mice. 
Ear, back and tail tissue was harvested from male WT K17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- 
mice at age P50. Protein was isolated from each sample and anti-K17, anti-γH2AX and anti-GAPDH 





γH2AX-positive cells are exclusively found in the epidermis and there is no 
apparent dependence on K17 status 
 Indirect immunofluorescence microscopy for γH2AX has been used as an indicator 
of DNA damage in a wide variety of cancer research (Bonner et al., 2008; Ivashkevich et al., 
2012; Qvarnström et al., 2004). In order to investigate the cellular localization of γH2AX foci 
in murine epidermis and to substantiate the Western blot data reported above, ear, back and 
tail tissue was harvested from P50 male mice, snap-frozen in OCT compound, and 6-8 μm 
cryosections were produced. Male mice were exclusively assessed as there was no difference 
in the trends evident between male and female mice via immunoblot analyses, although a more 
exhaustive evaluation could be conducted in the future by including female mice. Sections 
from WT; Krt17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- mice were stained for γH2AX 
and total signal was quantified by averaging the pixel intensity across greater than 5 images 
above a threshold established by wild-type samples (n=3 biological replicates). On the basis 
that ear and back samples exhibited the most pronounced γH2AX signal, representative ear 
and back images are shown (Figure 10, 11 and 12) (tail tissue data not shown).  
 As observed in all three male biological replicates, γH2AX signal is found exclusively 
in the epidermis. The white dotted line in all reported images represents the epidermal-dermal 
junction and the positive cells found on the dermal side of this divide are actually in the hair 
follicle. This finding is in accord with the established K14-HPV16Tg/+ model of SCC, as K14 
is constitutively expressed in basal cells of the epidermis (Coulombe et al., 1989; Nelson and 
Sun, 1983). Additionally, it appears that the highest signal, pan-nuclear stained cells are seen 
in the outer layers of the epidermis (Marti et al., 2006).  
 In all three of the male biological replicates, total γH2AX intensity is higher in the 
HPV16Tg/+ setting as compared to wild-type for both ear and back tissue (Figures 10, 11 and 
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12). In two of the three HPV16Tg/+; Krt17-/- ear sections γH2AX levels were higher than the 
corresponding HPV16Tg/+; Krt17+/- samples (Figures 10 and11). In one of the replicates, 
γH2AX intensity was higher in the HPV16Tg/+; Krt17+/- ear sample, indicating some degree of 
variability exists in the presence or absence of K17 (Figure 12). Furthermore, back samples 
from the biological replicates demonstrated a similar variability, with only one set of mice 
displaying a significant difference between the HPV16Tg/+; Krt17-/- and HPV16Tg/+; Krt17+/- 
settings (Figure 11). Cumulatively, these results suggest there is an inherent variability in DNA 
damage between HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- mice, with no apparent 











Figure 10. γH2AX levels in HPV16Tg/+ mice vs wild-type; male biological replicate 1.  
Immunofluoresence microscopy images for (a) ear tissue and (b) back tissue (6-8 μm thickness). Top panel 
costained for DAPI and γH2AX. Bottom panel is the single channel for γH2AX. From left to right for 
both (a) and (b): WT; Krt17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- genotypes. E= epidermis, D= 
dermis; white dotted line separates epidermis and dermis. Quantification of γH2AX levels normalized to 
































Figure 11. γH2AX levels in HPV16Tg/+ mice vs wild-type; male biological replicate 2.  





























Figure 12. γH2AX levels in HPV16Tg/+ mice vs wild-type; male biological replicate 3.  




















A tissue specific gradient is established in both male and female mice for the 
HPV16Tg/+ model 
Ear tissue of the K14-HPV16Tg/+ mouse line is well documented as the most 
consistently affected site by squamous cell carcinoma lesions (Arbeit and Hanahan, 1994). 
Additionally, substantial research has been conducted on this model in a variety of other 
tissues, including cervical epithelium and oral epithelium, among others (Hobbs et al., 2016; 
Sdek et al., 2006).  
To test whether the extent of DNA damage varies by tissue site, we directly compared 
by Western blotting ear, back and tail protein isolates in triplicate and separated by genotype. 
Herein, we define a tissue specific gradient in both the HPV16Tg/+; Krt17+/- and HPV16Tg/+; 
Krt17-/- settings, but not in WT; Krt17+/- mice. In female HPV16Tg/+; Krt17+/- mice, as would be 
expected, ear tissue exhibited the most significant amount of DNA damage, followed by back 
and tail tissue (Figure 13). Due to the fact that tail tissue exhibited the lowest level of total 
γH2AX, ear and back isolates were normalized to tail and displayed as a fold increase. In 
HPV16Tg/+; Krt17+/- mice, the gradient Ear>Back>Tail was statistically significant across all 
comparisons (Ear:Back, p=0.003; Ear:Tail, p=0.003; Back:Tail, p=0.03) (Figure 13, middle 
panel). Similarly, in HPV16Tg/+; Krt17-/- mice, this discordance was also significant (Ear:Back, 
p=0.002; Ear:Tail, p=0.001; Back:Tail, p=0.04) (Figure 13, lower panel). Although a 
comparable pattern was seen in the respective male analyses, no statistical significance was 
reported, in part due to the reduced sample size and consequent reduced power (Figure 14). 
However, both HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- male mice exhibited this trend 
(Figure 14, middle and lower panels).  
Both male and female biological replicates were pooled in order to ascertain whether 
this trend remained true across both sexes. Accordingly, pooled data sets were analyzed and 
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in both HPV16Tg/+ settings this Ear>Back>Tail gradient was apparent (Figure 15). For 
HPV16Tg/+; Krt17+/- mice: Ear:Back, p=0.014, Ear:Tail, p=0.007 and Back:Tail, p=0.029. For 
HPV16Tg/+; Krt17-/- mice: Ear:Back, p=0.0007, Ear:Tail, p=0.0002 and Back:Tail, p=0.16. 
These data suggest that additional skin sites exhibit DNA damage in a gradient dependent 











Figure 13. Tissue discordance in γH2AX levels in female mice.  
Comparison of γH2AX levels across ear, back and tail tissues from each of the genotypes in female mice. 
Left hand panel contains Western blots from each of the three genotypes in this study. Anti-K17, anti-
γH2AX and anti-Histone H3 antibodies were utilized. Right hand panel illustrates the quantification of 













Figure 14. Tissue discordance in γH2AX levels in male mice.  
Comparison of γH2AX levels across ear, back and tail tissues from each of the genotypes in male mice. 
Left hand panel contains Western blots from each of the three genotypes in this study. Anti-K17, anti-
γH2AX and anti-Histone H3 antibodies were utilized. Right hand panel illustrates the quantification of 








































Figure 15. Tissue discordance in γH2AX levels in both male and female mice.  
Pooled male and female data of γH2AX protein levels in ear, back and tail samples for WT; Krt17+/-, 
HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- genotypes. N≥5 for all samples. Horizontal black bars indicate 
the average for each data set.  
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Quantitative RT-PCR reveals variable expression of DNA damage response 
elements independent of K17 status  
To dissect whether the gene expression patterns of well-known DNA damage-
associated proteins were altered in the presence or absence of K17, qRT-PCR assays were 
conducted for Atm, Atr, Chk1, Chk2, Foxm1, Trp53 and Xrcc5. Gene expression levels were 
compared for ear, back and tail tissue sections across all genotypes for male and female mice 
(n=3 biological replicates) and values were expressed as a fold change over WT; Krt17+/- 
counterparts. Essentially, these findings indicate variable expression across tissue site and 
genotype for a number of the DNA damage-associated genes.  
Qualitatively, it appears that there was higher expression of Atm and Chk1 in male 
mice compared to females, although this was not quantitatively ascertained from the data 
(Figure 16, top panel). Moreover, for these two genes, no statistical significance was evident 
across all experimental parameters, with the exception of Atm in ear tissue of HPV16Tg/+; 
Krt17+/- versus HPV16Tg/+; Krt17-/- male mice (p=0.045).  
Greater differences between WT and HPV16Tg/+ settings were apparent in the qRT-
PCR data for the Atr and Chk1 targets (Figure 16, middle panels). In particular, the transcripts 
of both Atr and Chk1 were upregulated in HPV16Tg/+ male ears compared to wild-type 
(p<0.05 for all: See figure 16) with no significant disparity upon K17 ablation. However, this 
trend was only apparent in Atm levels in female HPV16Tg/+; Krt17-/- back tissue (p=0.003), 
potentially as a result of inter-biological replicate variations or sex-based differences in 
response to DNA damaging events.  
Multiple comparisons between the transgenic genotypes and wild-type mice indicated 
significant differences in Foxm1 expression. Foxm1 is a proliferation associated gene with both 
initiation and promotion-associated roles attributable to the protein product, FOXM1 
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(Wierstra and Alves, 2007). HPV16Tg/+ male ear and back tissue exhibited elevated Foxm1 
levels compared to wild-type with no dependence on K17 status (p<0.05: See Figure 16, 
bottom panel). Similarly, HPV16Tg/+ female back and tail tissue displayed a comparable trend, 
despite no differences in RNA from ear tissue.  
The Trp53 gene encoding for the P53 protein is downregulated in HPV16Tg/+ female 
mice compared to wild-type across all tissue sites (statistically significant p<0.05 in back and 
tail tissue) along with male ears (p<0.02). This finding is unusual as it is known that the 
established mechanism for HPV infection involves the proteolytic degradation of P53 by the 
E6 oncoprotein of the HPV16 genome. Additionally, and somewhat surprisingly, we observed 
that Xrcc5, a direct target of P53, exhibited a similar downregulation in female mice (p<0.05) 













Figure 16. qRT-PCR analyses of DNA damage response-associated gene expression changes 
RNA isolated from ear, back and tail tissues of WT; Krt17+/-, HPV16Tg/+; Krt17+/- and HPV16Tg/+; Krt17-/- 
male and female mice was assessed for changes in notable DDR-associated genes. All values are exhibited 
as a fold change over WT. *P<0.05; **P<0.02. Error= upper and lower limit of standard error.   
Xrcc5 
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K17 appears to be induced upon treatment with the mutagen, DMBA, compared 
to control 
 DMBA, a polycyclic aromatic hydrocarbon, is a potent carcinogen that is known to 
have deleterious effects on DNA after systemic exposure, forming a wide variety of DMBA-
DNA adducts (Dipple et al., 1984; Slaga et al., 1974; Ward et al., 1986). Specifically, DMBA 
frequently induces an activating A to T transversion in codon 61 of the Hras1 gene, a notable 
oncogene (Brown et al., 1990). Moreover, DMBA is a commonly utilized initiating agent in 
two-step chemical carcinogenesis experimental protocols (Abel et al., 2009).   
As a means of determining whether K17 is induced upon acute DNA damage, male 
mice were administered either 100 μg DMBA (in 200 μl of acetone vehicle) or 200 μl of 
acetone control via intraperitoneal (IP) injection and back tissue sections were harvested 7 
days later. Indirect immunofluorescence microscopy images stained for both K17 and γH2AX 
suggest that γH2AX expression is induced upon treatment with DMBA compared to acetone 
control (Figure 17, lower panels). More promisingly, K17 levels appear to be elevated in the 
treated male mice compared to control (Figure 17, upper panels). This finding, although 
























Figure 17. K17 may be induced upon systemic treatment with the mutagen, DMBA.  
Six-week-old male mice IP injected with either 100μg DMBA (200 μl volume) or acetone (200 μl volume) 
and back tissue harvested and embedded in OCT one week later. Top panel depicts K17 staining and 
bottom panel illustrates γH2AX staining in acetone versus DMBA injected mice. Scale bars, 50 μm. Figure 





 The research described in this thesis uncovers new details regarding the HPV16Tg/+ 
model for SCC in addition to offering preliminary insight about the relationship between K17 
and DNA damage. 
 Stemming from the extensively reported observations that K17 is induced in a variety 
of stress/inflammatory settings, and coupled with the knowledge that K17 directly impacts 
the course of tumorigenesis through a number of mechanisms, we set out to elucidate whether 
K17 plays a role in response to an acute challenge with a DNA mutagen. This acute model is 
a particularly logical and appropriate context since it draws upon the inducible nature of K17 
and provides a definitive window that parallels the initiation stage of carcinogenesis. Our 
preliminary findings indicate that the systemic treatment of the mutagen, DMBA, elicits an 
upregulation of K17 concurrent with elevated DNA damage in murine back tissue, as 
represented by γH2AX staining. Notably, K17 induction appears to be localized to the basal 
layer, which contains the most proliferative cells of the epidermis (Potten, 1974). As DNA 
damage is an initiating event, and the clonal expansion of initiated cells is necessary for the 
eventual development of tumors, the contemporaneous elevation of K17 and γH2AX levels 
in the basal layer suggests that K17 may play a role in the initiating events of carcinogenesis.  
Conversely, the properties of DMBA and its cellular effects may in fact pose a more 
significant complication than initially thought when ascertaining K17 involvement in initiation 
versus promotion stages. Prior in vivo studies of DMBA have identified a number of additional 
effects, in addition to DNA adduct formation. Using common inflammatory (i.e. tumor 
promotion) experimental readouts including edema, hyperplasia and polymorphonuclear 
leukocyte infiltrates (measured by MPO), Frenkel et al. (1995) demonstrated that there was 
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substantial overlap between the physiological effects of DMBA and TPA. Furthermore, for 
both the MPO assay and detection of edema, DMBA treatment led to a more prolonged 
elevation in levels compared to TPA treatment. DMBA treatment resulted in oxidative effects 
and stimulated a similar inflammatory profile to that of the promoting agent, TPA, highlighted 
by the production of hydrogen peroxide (Frenkel et al., 1995). Coincidentally, previous 
research in the Coulombe laboratory showed that K17 is phosphorylated on Serine 44 in 
response to hydrogen peroxide-induced oxidative stress, an event that modulates protein-
protein interactions and downstream K17-mediated signaling events (Pan et al., 2011). This 
may attribute what is a supposed DMBA-induced response to already established functional 
roles of K17 as opposed to the oncogenic event itself.  
To further substantiate these observations, a number of experimental factors could be 
optimized in future studies. The current data presented in this thesis is from a study of one 
DMBA-treated and one acetone-treated mouse. A more robust sample size would solidify 
whether K17 induction occurs in a statistically significant manner. Additionally, the route of 
DMBA administration chosen was IP injection. Considerable research conducted on the two-
step chemical carcinogenesis model has traditionally implemented topical DMBA treatments, 
although IP injections are also an effective method (DiGiovanni, 1992; Ward et al., 1986). 
Accordingly, ascertaining the comparative DNA damage in this model as a consequence of 
systemic or topical treatments could prove fruitful for future work.  
 Another parameter that deserves further attention is the time point at which tissue is 
harvested after DMBA treatment. In this study, mice were treated and tissue was harvested 7 
days later. The reasoning behind this was that a broader analysis of putative K17 induction 
upon DNA damage would be followed by more stringent time points to definitively narrow 
down when K17 may be switched on. The discrepancy between the rapid phosphorylation of 
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H2AX to γH2AX (some studies indicating it occurs as quickly as 3-10 minutes after IR 
exposure) and the harvest time point does permit substantial variation in K17 levels to occur 
if the induction is transient (Rothkamm and Horn, 2009). To this effect, what may prove useful 
are in vitro assays to narrow down the window in which K17 induction may occur in response 
to DMBA, due to less susceptibility to inter-biological replicate variations and their relative 
ease. Such studies are currently in progress in the Coulombe laboratory.  
In order to complement the acute model for investigating K17 involvement in DNA 
damage in skin, the HPV16Tg/+ mouse was used as a corollary for the ‘chronic’ development 
of tumors (specifically SCC) in epidermal tissue. Two principal pieces of information were 
used in the experimental design: 1) K17 is robustly induced in the interfollicular epidermis of 
HPV16Tg/+ mice between P20 and P40 and 2) SCC lesion development arises at P60 with 
complete penetrance by P120 (Hobbs et al., 2015). Hence, the P50 time point is considered 
pre-lesional and is analogous to the initiation stage of carcinogenesis. This research proposes 
that the presence of K17 does not impact the extent of DNA damage in mouse skin from any 
tissue site sampled, namely ear, back and tail. As a validation of this experimental design, there 
is a stark difference in γH2AX levels between wild-type and the transgenic model, reinforcing 
these findings. Furthermore, these observations held true for both of the most afflicted tissues, 
ear and back.  
A closer examination of the Western blot data for female mice does suggest that there 
is a difference in γH2AX signal between HPV16Tg/+; Krt17-/- and HPV16Tg/+; Krt17+/- mice, 
although not statistically significant (P=0.06). This particular observation could benefit from 
an increased sample size (n=3 biological replicates in this data set) to determine whether the 
decrease in γH2AX signal in HPV16Tg/+; Krt17-/- female mice would be of biological 
significance. Moreover, this finding, despite lacking statistical significance, appears to be 
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somewhat divergent from the more concrete male data that does not indicate K17-dependent 
DNA damage. Substantial efforts focused on other inducible keratins (K16 in particular) in 
the Coulombe laboratory have revealed sex-based differences in a variety of disease settings, 
most notably PC (unpublished data). Thus, a sex-based variance in DNA damage may explain 
the discrepancy in the male and female data sets.  
What is apparent from the analysis of the immunofluorescence microscopy images is 
that there appears to be some degree of variability in γH2AX expression levels across 
biological replicates. In particular, for two of the three replicates, HPV16Tg/+; Krt17-/- ear tissue 
had more γH2AX-positive cells than the HPV16Tg/+; Krt17+/- counterparts, largely confirmed 
by Western blotting. This variability could extend from the fact that there is inherent variation 
in tumor onset and thus pinpointing the exact times at which oncogenic insults occur in pre-
lesional tissue of HPV16Tg/+ mice may prove temporally difficult (Hobbs et al., 2015). 
Alternatively, this model does not account for potential inherent differences in mutational load 
between biological replicates and thus differences in γH2AX signal between HPV16Tg/+; Krt17-
/- and HPV16Tg/+; Krt17+/- samples could be attributed to intra-strain fluctuations.  
 The phosphorylation of H2AX on Ser 139 is an early chromatin modification upon 
the initiation of DSBs during apoptosis (Rogakou et al., 2000). In both of the previously used 
models of K17 in carcinogenesis (Gli2- BCC and K14-HPV16Tg/+- SCC), it was reported that 
K17 did not impact apoptosis (DePianto et al., 2010; Hobbs et al., 2015). Rather, K17-driven 
cell proliferation was a central component of its contributions to carcinogenesis. Accordingly, 
the apparent localization of γH2AX-positive cells by immunofluorescence microscopy in both 
the HPV16Tg/+; Krt17-/- and HPV16Tg/+; Krt17+/- settings is most likely not indicative of 
apoptotic cell death. Cells in the basal layer are destined for either continued proliferation or 
terminal differentiation, the latter of which would provide a context for apoptosis (Cotsarelis 
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et al., 1990). However, in this HPV16Tg/+setting, there are profound perturbations in terminal 
differentiation of keratinocytes, underscoring that the γH2AX-positive cells are a result of this 
particular SCC model and K17 involvement is not complicated by normal physiological 
processes (Arbeit et al., 1994). 
 Future research efforts could focus on the potential for DNA damage initiating events 
during the period where K17 exhibits the most robust upregulation in this transgenic mouse 
model: P20 to P40. The limitations of in vivo models like the one at hand are that it becomes 
challenging to determine when oncogenic insults occur prior to obvious macroscopic lesion 
development. The transgene in the HPV16Tg/+ mice is kicked on in embryonic development, 
however the 60-day window between this and lesion development is a rather large timeframe 
to investigate K17-dependent DNA damage. It may well be that the explanation for the 
previously reported strong upregulation of K17 between P20 and P40 is attributable to 
initiating events and that the genetic ablation of K17 in this window would be of significant 
biological relevance.  
The increased presence of γH2AX in both HPV16Tg/+; Krt17-/- and HPV16Tg/+; Krt17+/- 
mice does not necessarily indicate that DDR effector molecules are more abundant. Indeed, 
protein abundance is not necessarily indicative of elevated gene expression and thus the two 
analyses are intended to be complementary in understanding the cellular underpinnings of 
carcinogenesis and other disease settings (Greenbaum et al., 2003). To resolve a holistic picture 
of the role of K17 in DNA damage, qRT-PCR assays were run for a number of notable DDR 
genes. These included genes for the ATM-CHK2 and ATR-CHK1 signaling pathways, along 
with Trp53, Foxm1 and Xrcc5 which are distinctively upregulated in response to DNA damage 
(a detailed description of each can be found in Appendix A).  
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The ATM-CHK2 pathway is necessary for the phosphorylation of H2AX to γH2AX 
(Smith et al., 2010). Additionally, this pathway preferentially responds to DSBs and it is known 
that HPV viral integration in the basal cells of the epidermis requires DSBs (Arbeit et al., 1994). 
One may expect that the gene expression of Atm and Chk2 is elevated in the HPV16Tg/+ setting 
however it appears that no significant elevation occurs across both genotypes and all tissue 
sites sampled, with a slightly more pronounced change in males compared to females. In male 
ear tissue, there was a statistically significant upregulation of Atr and Chk1 compared to wild-
type and no discernible dependence on K17 status. As ear tissue is the most frequent site for 
SCC lesion development, this suggests that DNA damage is occurring prior to lesion 
development and K17 does not significantly attenuate or exacerbate this.    
A more conclusive observation from the qRT-PCR data is that there is significant 
variability in gene expression between biological replicates. Additionally, the differences in 
DNA damage by γH2AX detection in immunofluorescence microscopy and Western blotting 
analyses is not entirely reflected at the transcriptional level, based on the expression of the 
known effectors of the H2AX to γH2AX phosphorylation event. What may explain this is 
that the kinase activity of ATM is increased in response to DNA damage as opposed to a 
substantial elevation of the Atm transcript (Burma et al., 2001). Alternatively, the ‘window’ for 
DNA damage may occur earlier than P50 resulting in lower than anticipated transcript levels 
for these DDR genes.  
Analyses of the Xrcc5 and Trp53 expression levels provides additional intriguing insight 
into the HPV16Tg/+ model. The E6 oncoprotein of the HPV genome specifically targets and 
degrades the P53 protein product. Based on the qRT-PCR data in this thesis, it appears that 
the expression of Trp53 is reduced in all tissue sites of female mice and the ear tissue of male 
mice, suggesting that P53 degradation is apparent, although one cannot conclusively relate the 
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protein and transcript data (Scheffner et al., 1990). In turn this may have deleterious effects on 
the transcriptional activation of subsequent targets involved in the DNA damage response 
(Fields and Jang, 1990; Raycroft et al., 1990). Downregulation of Xrcc5 expression, a gene 
encoding for the Ku-related protein (Ku 80) involved in DSB repair, is evident, to some extent, 
in the RNA isolated from female tissue and male ear tissue for qRT-PCR analyses. This 
downregulation is contrary to previous reports in which an inactivating mutation of the P53 
protein resulted in the modulation of Xrcc5, a gene normally repressed by P53 (Chao et al., 
2006; Taccioli et al., 1994). One would expect increased Xrcc5 in this setting as P53 is degraded 
by the E6 oncoprotein and, as such, enables Xrcc5 to produce the Ku80 (X-ray repair cross-
complementing protein 5) protein product involved in DSB repair. However, further 
complicating these observations is the recently published work that P53 directly represses 
transcription of K17 in the stress-related setting, radiation dermatitis, signifying that the 
proteolytic degradation of P53 should not alter any potential DNA-damage induction of K17 
in its absence (Liao et al., 2016).  
One piece of evidence that may allude to the fact that K17 is more closely associated 
with the promotion phase of carcinogenesis as opposed to initiation, is the upregulation of the 
Foxm1 gene across a number of the tissue samples in both genotypes. A prominent role of 
FOXM1, the protein product of the Foxm1 gene, is in the stimulation of cell growth and 
proliferation by promoting G1/S and G2/M-transitions and enabling the proper execution of 
mitosis (Wierstra and Alves, 2007). Admittedly, FOXM1 has a dual capacity for both initiation 
and promotion-associated functions (Wierstra and Alves, 2007). However, this data, taken in 
the context of the “underwhelming” upregulation of DDR-associated genes, may be an initial 
clue into the exclusive role of K17 in the promotion stage of tumorigenesis. 
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Collectively, the qRT-PCR analyses, although admittedly somewhat variable and 
challenging to dissect, may provide novel information for this chronic model for studying K17 
involvement in DNA damage. The fact that the early gene (E6 and E7) protein products 
degrade central DDR components as a means of initiating subsequent SCC lesion 
development, may highlight that these perturbations in DDR pathways discount the protein 
and/or gene expression changes of DDR elements as an applicable readout for determining 
the effect of K17 genetic ablation on DNA damage itself.  
Lastly, a tissue-specific gradient of DNA damage in the HPV16Tg/+ model has not yet 
been reported. What has been previously established is that ear tissue is the most frequently 
observed site for the development of SCC lesions, ultimately exhibiting full penetrance (Hobbs 
et al., 2015). However, this study reports that tissue sites in this model are differentially affected 
by DNA damage in a statistically significant manner. In both male and female mice, 
immunoblotting revealed a hierarchy of DNA damage is established: ear>back>tail, which 
was not evident in the corresponding wild-type tissue samples.  
An initial conclusion may be that this is due to differential cellular turnover rates in 
murine tissues, yet prior research has indicated that dorsal and ear skin exhibit roughly 
comparable rates of cell production (Potten, 1975). An alternative rationale is that ear tissue 
in HPV16Tg/+ mice are characterized by progressive hyperplasia and thus a direct comparison 
of ear and back tissue does not fully take into account the differences in epidermal thickness. 
Although this is a reasonable assertion, this does not shed light on why back and tail tissue are 
differentially affected. Further, analyses normalizing for area (data not shown) indicate that 
the difference between ear and back γH2AX expression levels is largely sustained by this 
manipulation. Ultimately, the physiological mechanism by which SCC lesion development 
arises in such a striking fashion in the ear tissue of HPV16Tg/+ mice is not understood. 
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Nevertheless, this research validates this well-documented phenomenon and provides 
evidence for the presence of DNA damage in other tissue sites. 
The role of K17 in modulating the inflammatory response and promoting tumor 
growth in a number of different cancer settings is well established (Depianto et al., 2010; 
Hobbs et al., 2015). Despite this substantial knowledge, it is not known, functionally, how K17 
might specifically contribute to the distinct stages of carcinogenesis. What extends from this 
body of work is that K17 appears to be upregulated in an acute, ‘inducible’ setting, an 
observation that is not seen in the HPV16Tg/+ chronic model of DNA damage initiation. 
Further assessment of DDR-associated genes by qRT-PCR indicates variable expression 
patterns with potential insight into the HPV16Tg/+ initiated tumorigenesis model that may 
prompt a closer consideration of the experimental readouts used in these studies. Additionally, 
new insight into the K14-HPV16Tg/+ model for squamous cell carcinoma is put forth. 
Although the recurring theme of the complex nature of K17 expression and its significance is 
apparent, continued efforts to dissect the involvement of K17 in distinct carcinogenic 
properties is essential.  
The findings reported in this thesis, when coupled with the body of work produced in 
the Coulombe laboratory and others, underscore the significant relevance of K17 in a number 
of disease settings. The potential role of K17 in DNA damage processes will add further 
impetus for the future study of K17 in the specific stages of carcinogenesis. To expand on our 
knowledge of K17 involvement in DNA damage, future efforts could be directed at the 
following: i) in vitro analyses that can provide further mechanistic insight, for example, whether 
K17 is modified in response to DNA damaging agents, ii) a more robust analysis of the 
timepoint at which K17 may be involved in DNA damage in the HPV16Tg/+ model, iii) an 
evaluation of a potential K17-DNA damage relationship in the extant Gli2tg mouse model in 
 47 
the Coulombe laboratory and iv) further delineation of whether K17 is responsive to acute 
DNA damage events such as challenge with the mutagen, DMBA. 

















MATERIALS AND METHODS  
 
Mouse Models 
All experimental protocols involving mice were approved by the Johns Hopkins 
Institutional Animal Care and Use Committee. Genotyping for the HPV16Tg/+ and Krt17 alleles 
was conducted according to established protocols (National Cancer Institute Mouse 
Repository, strain 01XT3; McGowan et al., 2002). 
 
HPV Transgenic Mice 
C57BL/6 Krt17-/- mice were bred to K14-HPV16 (HPV16Tg/+) mice (FVB/N strain; 
obtained from the National Cancer Institute Mouse Repository, strain 01XT3) to generate 
HPV16Tg/+; Krt17-/-. Subsequently, HPV16Tg/+; Krt17-/- mice were backcrossed with FVB/N 
mice for at least six generations. HPV16Tg/+; Krt17+/- mice were utilized in place of HPV16Tg/+; 
Krt17+/+ due to morphological and phenotypic similarities between the genotypes. All mice 
were fed rodent chow and water ad libitum upon weaning. Both male and female mice for 
HPV16Tg/+; Krt17+/-, HPV16Tg/+; Krt17-/- and WT; Krt17+/- genotypes were euthanized and ear, 
back, tail and liver samples were harvested for histology, RNA and protein isolation at P50. 
Mice deemed sickly by veterinary staff were excluded from this study. The sample size of mice 
required for this study was empirically determined from previous experience and established 





DMBA and Acetone Mouse Treatments 
Male WT; Krt17+/- (FVB/N) mice were IP injected with either 100 µg DMBA (Sigma-
Aldrich, St. Louis, MO, USA) in 200 µl of volume or acetone (Fischer Scientific, Fair Lawn, 
NJ, USA) at P40. DMBA was dissolved in acetone the morning of injections. Mice were 
anesthetized using short exposure to 20% isoflurane (v/v in propylene glycol) and 
subsequently IP injected using 1 ml 26G x 3/8 syringes (BD, Franklin Lakes, NJ, USA). Mice 
were housed separately based on the treatment administered and euthanized 7 days later. Back 
tissue was harvested from the DMBA and acetone treated mice and embedded in Tissue-Tec 
OCT compound (Sakura Finetek, Torrance, CA, USA).  
 
Tissue Collection and Histology 
Ear, back, tail and liver tissues were harvested from three to four mice for each 
genotype (HPV16Tg/+; Krt17+/-, HPV16Tg/+; Krt17-/- and WT; Krt17+/-) and sex in the HPV16Tg/+ 
setting. Back tissue was harvested for the male WT; Krt17+/- DMBA and acetone treated mice. 
All tissue sections were quickly embedded in Tissue-Tec OCT compound (Sakura Finetek, 
Torrance, CA, USA) and stored at -20°C prior to sectioning. Tissue sections were cut at 6-8 
μm in thickness and subsequently subjected to histological stains.  
 
Protein and RNA Isolation  
The four tissues harvested from the HP16Tg/+ mice, as indicated above, were prepared 
for RNA, DNA and protein isolation using Trizol reagent (Invitrogen, Carlsbad, CA, USA). 
Tissue was homogenized for >5 minutes and directly underwent phase separation. Protein, 
RNA and DNA were isolated for each sample as directed by the manufacturer’s protocol. 
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Protein lysates were prepped for Western blotting in urea sample buffer (8 M deionized urea, 
0.5% SDS, 30 mM Tris, pH 6.8, 5% glycerol and 5% β-mercaptoethanol). All samples were 
sheared using progressively thinner gauged needles (18, 20, 22 ½, 25 ½ and 26 ½). 
Concentration for protein lysates was determined using an amido black assay and 
biophotometer (Eppendorf, Hamburg, Germany). RNA purity and concentration 




The primary antibodies used in these studies included rabbit polyclonal antibodies 
against Krt17 (developed in-house; 5th bleed), histone H3 (Cell Signaling #9715, Danvers, MA, 
USA), normal rabbit IgG (Santa Cruz Biotechnology sc-2027, Dallas, TX, USA) and phospho-
γH2AX (Cell Signaling #9718, Danvers, MA, USA); mouse polyclonal antibodies against 
GAPDH (Santa Cruz Biotechnology sc-365062, Dallas, TX, USA). Secondary antibodies 
included ones conjugated to Alexa Fluor 488 (Abcam, Cambridge, UK) for indirect 
immunofluorescence and horseradish peroxidase (HRP)-conjugated goat anti-mouse and goat 
anti-rabbit antibodies (Sigma-Aldrich, St. Louis, MO, USA) for chemiluminescence 
immunoblotting. 4’,6-Diamidine-2’-phenylindole dihydrochloride (DAPI) (Roche 
10236276001, Mannheim, Germany) was used as a nuclear marker for indirect 






Western Blotting, Indirect Immunofluorescence and Microscopy 
All samples were loaded at 10-20μg of protein per lane for immunoblotting. Samples 
were separated using either 10% or 12.5% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis and transferred to 0.45µm nitrocellulose membranes (Bio-Rad, Hercules, CA, 
USA) via a trans-blot turbo transfer system (Bio-Rad). Blots were blocked in 5% milk in PBS-
T (w/v) for >1hr at room temperature (21°C) and subsequently incubated overnight at 4°C 
in their appropriate antibodies. Secondary antibodies were applied for 1hr at room temperature 
(21°C). Blots were developed using either ECL Select developing solution (GE Healthcare, 
Pittsburgh, PA, USA) or SuperSignal West Pico chemiluminescent substrate (Thermo 
Scientific, Waltham, MA, USA) and imaged using a FluorChem Q system (ProteinSimple, San 
Jose, CA, USA).  
For indirect immunofluorescence analysis, frozen sections of the aforementioned 
tissues were blocked for 1hr at room temperature (21°C) in 5% normal goat serum in 1X PBS. 
Primary antibodies were applied overnight at 4°C. Tissue sections were imaged using a Zeiss 
fluorescence microscope with Apotome attachment. Images for the same marker, across all 
samples, genotypes and tissue types, were acquired at the same exposure, pixel range, gamma 
values and objective using Zen software. All images were consistently adjusted for brightness 
and contrast and appropriately cropped for presentation purposes using ImageJ software. 
 
Image Quantification, Graphical Analysis and Description of Statistical 
Methods 
Signal intensity quantification for Western blots and phospho-γH2AX 
immunofluorescence images was performed using ImageJ software. Western blot 
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densitometry values were normalized to loading control (either GAPDH or histone-H3) and 
averaged across the value of interest (genotype or tissue type).  
Indirect immunofluorescence calculations were based upon quantification of ≥5 
images for each tissue, biological replicate n≥3 and genotype at 20X magnification. γH2AX 
intensity was restricted to the epithelium. Wild-type samples were used as a baseline for 
thresholding the minimum value of γH2AX intensities due to the apparent lack of γH2AX 
foci. The threshold value was set for each tissue and set of genotypes and applied across all 
subsequent images that were quantified. Graphs accompanying IF images represent the 
average total pixel count of γH2AX foci in the epidermis of each set of images. Error bars in 
immunoblot quantification represent the standard error of the mean (s.e.m.). Error bars in the 
quantification of immunofluorescence images represent technical error across replicate 
images. All P-values were generated using a Student’s t-test with two-sided distribution and 




Isolated RNA was purified using Nucleospin RNA Clean-Up (Macherey-Nagel, 
Düren, Germany). RNA (1 ug) was reverse transcribed using iScript cDNA Synthesis Kit (Bio-
Rad, Hercules, CA, USA). qRT-PCR was performed on the first-strand cDNA using the 
qPCRBIO PureGreen Mix (Next Day Science, Rockville, MD, USA). The PCR parameters 
for the qRT-PCR screen included incubation at 95 °C for 5 min followed by 40 cycles of 95 
°C for 10 s and 60 °C for 30 s (58°C for the Chk2 primer set). Controls with no template or 
no reverse transcriptase, standard curves and a melt curve were included on every PCR plate. 
Normalized expression values from the qRT-PCR data were calculated using Microsoft Excel 
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by first averaging the relative expression for each target 
gene  across all three biological replicates. Error bars 
were derived from the standard error of the ΔCq values (Cq target − Cq reference) across all biological 
replicates. Actb and Gapdh were used as reference genes. A list of all qRT-PCR primers used is 
listed in Table 1. 
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Table 1. Table of forward and reverse primer sequences used in qRT-PCR analyses of ear, 
back and tail tissue. 
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APPENDIX A  
 
Atm 
ATM, ataxia telangiectasia mutated protein, is responsible for the 
phosphorylation of a number of downstream DDR proteins on serine or 
threonine residues. Upon DNA damage, this protein kinase activity is 
significantly increased, most notably through the phosphorylation of 
H2AX and the downstream CHK2 protein (Kurz and Lees-Miller, 2004). 
Atr 
ATR, ataxia telangiectasia and Rad3-related protein, is preferentially 
recruited to single-stranded DNA tracts and also functions by 
phosphorylating downstream proteins, specifically CHK1 and P53, which 
amplifies the DDR signaling pathways (Ciccia and Elledge, 2010; Tibbetts 
et al., 1999).  
Chk1 
The CHK1 protein is a pivotal protein kinase in controlling cell cycle 
progression. It is the downstream target of ATR and is phosphorylated in 
response to DNA damage or replication blocks to stall the cell cycle at the 
G2/M checkpoint (Liu et al., 2000).  
Chk2 
Chk2 gives rise to a stably expressed cell cycle protein product, CHK2, 
which is predominantly inactive unless cells are subject to DNA damage. 
Its activation is prompted by ATM-mediated phosphorylation in response 
to DSBs. In turn, CHK2 phosphorylates the N-terminal activation domain 
of P53, the cell cycle transcription factor E2F1 and additional downstream 
targets that activate cyclin-dependent kinases (CDKs) (Bartek and Lukas, 
2003; Cai et al., 2009). 
 
Foxm1 
FOXM1 is a gene that encodes for the forkhead box protein M1, a 
proliferation-associated transcription factor. It stimulates cell growth 
through the promotion of the G1/S- transition and the G2/M transition. 
Moreover, FOXM1 regulates the subsequent expression of a number of 
DNA damage sensing, mediating, signaling and repair genes (Wierstra and 
Alves, 2007; Zona et al., 2014). 
Xrcc5 
 
The protein product of the Xrcc5 gene, Ku80, is part of the Ku 
heterodimer that plays a pivotal role in the repair processes of DNA DSBs 
via the NHEJ pathway. Correspondingly, Xrcc5 gene expression is 
significantly upregulated in response to DNA damage and interacts with 
the notable repair proteins, such as p53 (Chao et al., 2006). 
Trp53 
The Trp53 gene, the mouse equivalent of the human TP53 gene, provides 
instructions for making the tumor suppressor protein, P53. P53 is a 
prominent DDR protein with a range of responsibilities from cell cycle 
arrest to regulating non-cell-autonomous interactions between damaged 
cells and the innate immune system (Reinhardt and Schumacher, 2012). 
 
Table 2. Description of qRT-PCR gene targets and the roles of the encoded proteins.  
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